Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Diabetes Reports|February 23, 2015
Diabetes after pancreatic surgery: novel issuesMarina Scavini, Erica Dugnani, Valentina Pasquale, et al.Cancer Biomarkers : Section a of Disease Markers|April 18, 2018
No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassayDaniela Liberati, Ilaria Marzinotto, Cristina Brigatti, et al.Acta Diabetologica|April 17, 2019
Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancerValentina Pasquale, Erica Dugnani, Daniela Liberati, et al.Diabetes|March 9, 2016
Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 DiabetesKerry A McLaughlin, Carolyn C Richardson, Aarthi Ravishankar, et al.Diabetes|October 16, 2014
CXCR1/2 inhibition blocks and reverses type 1 diabetes in miceAntonio Citro, Andrea Valle, Elisa Cantarelli, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 9, 2018
Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcomeErica Dugnani, Valeria Sordi, Silvia Pellegrini, et al.Scientific Reports|October 27, 2017
miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFAIlaria Marzinotto, Silvia Pellegrini, Cristina Brigatti, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 23, 2016
Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patientsErica Dugnani, Alessandra Gandolfi, Gianpaolo Balzano, et al.Acta Diabetologica|August 25, 2016
Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinomaErica Dugnani, Gianpaolo Balzano, Valentina Pasquale, et al.Pageof 2